High affinity human antibodies to tumor antigens
US6512097B1 · kind B1 · utility
57Cited by
1References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 20, 1999 |
| Grant date | Jan 28, 2003 |
| Priority date | — |
| Expiry date | May 20, 2019 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/71
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention provides novel chimeric molecules that specifically binds a tumor cell bearing a c-erbB-2. The chimeric molecules comprise an effector molecule attached to a C6 antibody that specifically binds to c-erbB-2. The chimeric molecules can specifically target and deliver effector molecules to cells overexpressing c-erb-B2.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.